We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine

    Objective

    This study aims to prepare candidate vaccines for cervical cancer immunotherapy by inserting the fused genes of human papillomavirus...

    Bing Wan, Lu Qin, ... He Wang in Infectious Agents and Cancer
    Article Open access 23 February 2022
  2. Comparative single-cell transcriptomic profile of hybrid immunity induced by adenovirus vector-based COVID-19 vaccines

    In this study, antibody response and a single-cell RNA-seq analysis were conducted on peripheral blood mononuclear cells from five different groups:...

    Melissa García-Vega, Hui Wan, ... Jesús Hernández in Genes & Immunity
    Article 03 April 2024
  3. Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration

    Distribution of vaccines which require refrigerated or frozen storage can be challenging and expensive. The adenovirus vector platform has been...

    Cheng Zhang, Adam Berg, ... Alexander D. Douglas in npj Vaccines
    Article Open access 05 June 2023
  4. Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner

    Recombinant adenovirus (rAd) regimens, including replication-competent oncolytic adenovirus (OAV) and replication-deficient adenovirus, have been...

    Miao Zeng, Wei Zhang, ... Li Yu in Biomarker Research
    Article Open access 25 March 2024
  5. Long-term trial of protection provided by adenovirus-vectored vaccine expressing the PPRV H protein

    A recombinant, replication-defective, adenovirus-vectored vaccine expressing the H surface glycoprotein of peste des petits ruminants virus (PPRV)...

    Karin E. Darpel, Amanda Corla, ... Carrie Batten in npj Vaccines
    Article Open access 03 June 2024
  6. Potent antitumor efficacy of human dental pulp stem cells armed with YSCH-01 oncolytic adenovirus

    Background

    Systemic administration of oncolytic adenovirus for cancer therapy is still a challenge. Mesenchymal stem cells as cell carriers have...

    Xu He, Wei Yao, ... Shou-Liang Zhao in Journal of Translational Medicine
    Article Open access 03 October 2023
  7. Adenovirus vector vaccination reprograms pulmonary fibroblastic niches to support protective inflating memory CD8+ T cells

    Pathogens and vaccines that produce persisting antigens can generate expanded pools of effector memory CD8 + T cells, described as memory inflation....

    Jovana Cupovic, Sandra S. Ring, ... Burkhard Ludewig in Nature Immunology
    Article 15 July 2021
  8. Biodistribution and immunity of adenovirus 5/35 and modified vaccinia Ankara vector vaccines against human immunodeficiency virus 1 clade C

    Previously, we developed a chimeric adenovirus type 5 with type 35 fiber (Ad5/35), which has high tropism to dendritic cells and low hepatoxicity....

    Masaru Shimada, Haibin Wang, ... Kenji Okuda in Gene Therapy
    Article 06 January 2022
  9. Vector Tropism

    Recombinant viruses expand the neurobiology toolbox and offer researchers an assortment of gene delivery options. Each type of virus varies in its...
    Shih-Heng Chen, Bo He, ... Negin P. Martin in Vectorology for Optogenetics and Chemogenetics
    Protocol 2023
  10. Oncolytic adenovirus encoding apolipoprotein A1 suppresses metastasis of triple-negative breast cancer in mice

    Background

    Dysregulation of cholesterol metabolism is associated with the metastasis of triple-negative breast cancer (TNBC). Apolipoprotein A1...

    Jie Dong, Lingkai Kong, ... Jiwu Wei in Journal of Experimental & Clinical Cancer Research
    Article Open access 03 April 2024
  11. SOCS3 inhibiting JAK-STAT pathway enhances oncolytic adenovirus efficacy by potentiating viral replication and T-cell activation

    Oncolytic viruses (OVs) are emerging as a potentially useful treatment for malignancies due to the capabilities of direct oncolysis and immune...

    Danmei Yan, Guannan Li, ... Qinglei Gao in Cancer Gene Therapy
    Article 15 December 2023
  12. Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines

    Vaccination has proven to be a valuable tool to combat SARS-CoV-2. However, reports of rare adverse reactions such as thrombosis/thrombocytopenia...

    Joshua Gardner, Simon Timothy Abrams, ... Dean J. Naisbitt in npj Vaccines
    Article Open access 05 June 2024
  13. Ixovex-1, a novel oncolytic E1B-mutated adenovirus

    There is a great demand for improved oncolytic viruses that selectively replicate within cancer cells while sparing normal cells. Here, we describe a...

    Mohiemen Anwar, Maja-Louise Arendt, ... Daniel Öberg in Cancer Gene Therapy
    Article Open access 20 May 2022
  14. Targeted shock-and-kill HIV-1 gene therapy approach combining CRISPR activation, suicide gene tBid and retargeted adenovirus delivery

    Infections with the human immunodeficiency virus type 1 (HIV-1) are incurable due the long-lasting, latent viral reservoir. The shock-and-kill cure...

    Sarah Klinnert, Corinne D. Schenkel, ... Karin J. Metzner in Gene Therapy
    Article Open access 09 August 2023
  15. Both chimpanzee adenovirus-vectored and DNA vaccines induced long-term immunity against Nipah virus infection

    Nipah virus (NiV) is a highly lethal zoonotic paramyxovirus that poses a severe threat to humans due to its high morbidity and the lack of viable...

    Mingqing Lu, Yanfeng Yao, ... Chao Shan in npj Vaccines
    Article Open access 04 November 2023
  16. Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: “Adenovirus Vaccine Within an Adenovirus Vector”

    Human adenoviruses (HAdVs) are highly contagious and result in large number of acute respiratory disease (ARD) cases with severe morbidity and...

    Yuqian Yan, Shu** **g, ... Qiwei Zhang in Virologica Sinica
    Article 26 May 2020
  17. BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors

    AdAPT-001 is an oncolytic adenovirus (OAV) with a transforming growth factor beta (TGF-ß) trap, which neutralizes the immunosuppressive and...

    Anthony P. Conley, Christina L. Roland, ... Santosh Kesari in Cancer Gene Therapy
    Article Open access 25 December 2023
  18. Adenovirus Vectors

    Infectious diseases are the prime cause of morbidity and mortality in animals leading to heavy economic losses to the livestock/poultry industry. One...
    Lisanework E. Ayalew, Amit Gaba, ... Suresh K. Tikoo in Viral Vectors in Veterinary Vaccine Development
    Chapter 2021
  19. Broad sialic acid usage amongst species D human adenovirus

    Human adenoviruses (HAdV) are widespread pathogens causing usually mild infections. The Species D (HAdV-D) cause gastrointestinal tract infections...

    Rosie M. Mundy, Alexander T. Baker, ... Alan L. Parker in npj Viruses
    Article Open access 26 September 2023
  20. Expression and Function of MAO A in Cardiac Cells by Means of Adenovirus-Mediated Gene Transfer

    Gene-transfer methods are useful to study the structural or functional roles of recombinant proteins in vitro. In particular, adenovirus-mediated...
    Yohan Santin, Angelo Parini, Jeanne Mialet-Perez in Monoamine Oxidase
    Protocol 2023
Did you find what you were looking for? Share feedback.